Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.
Ladenburg Thalmann Downgrades Calithera Biosciences to Neutral
Ladenburg Thalmann analyst Aydin Huseynov downgrades Calithera Biosciences (NASDAQ:CALA) from Buy to Neutral.
Related Posts
iQIYI Sports Announced Deal with Barça for Membership Program Allowing Fans in China to Watch all La Liga Games in the 2021/22 Season
iQIYI Inc. (NASDAQ: IQ) is pleased to announce that on September 14, the Company expands its existing strategic collaboration with Barça to develop a new premium membership program, "iBarça Membership".
Byline Bancorp Q3 EPS $0.69 Beats $0.56 Estimate, Sales $78.34M Beat $75.25M Estimate
Byline Bancorp (NYSE:BY) reported quarterly earnings of $0.69 per share which beat the analyst consensus estimate of $0.56 by 23.21 percent. This is a 102.94 percent increase over earnings of $0.34 per share from the
Credit Suisse Maintains Neutral on Bed Bath & Beyond, Lowers Price Target to $23
Credit Suisse analyst Lavesh Hemnani maintains Bed Bath & Beyond (NASDAQ:BBBY) with a Neutral and lowers the price target from $30 to $23.